Literature DB >> 22356652

Simultaneous detection of Hb constant spring (α142, TAA>CAA, α2) and the α2 IVS-I donor site (-TGAGG) deletion by a simple polymerase chain reaction-based method in Iran.

Haleh Akhavan-Niaki1, Ali Banihashemi, Amrollah Mostafazadeh, Vahid Kholghi Oskooei, Mandana Azizi, Reza Youssefi Kamangar, Maryam Mitra Elmi.   

Abstract

Hb Constant Spring (Hb CS, codon 142, TAA>CAA, α2) (HBA2:c.427T>C) and α2 IVS-I donor site (GAGGTGAGG>GAGG - - - - -) (HBA2:c.95+2_95+6delTGAGG) are nondeletional α-thalassemia (α-thal) mutations found all over the world. Identification of α-thal genotypes in at-risk couples for severe anemia or in highly heterogeneous populations requires rapid, accurate and cost-effective genotyping methods. In this study, a pair of primers were used to specifically amplify an 883 bp fragment from the α2-globin gene in order to simultaneously identify these two mutations by a PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) method. We determined the genotypic frequencies of Hb CS and the α2 IVS-I donor site mutations after amplification and enzymatic digestion with Tru9I in 238 northern Iranian samples referred for α-thal testing. Hb CS and the α2 IVS-I donor site mutations accounted for 21 (8.8%) and 29 (12.2%) of the nondeletional cases. This genotyping assay has proven to be a rapid, reliable and useful diagnostic tool for simultaneous detection of these two anomalies for genetic counseling or further prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356652     DOI: 10.3109/03630269.2012.657728

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  1 in total

1.  Hematologic features of alpha thalassemia carriers.

Authors:  Haleh Akhavan-Niaki; Reza Youssefi Kamangari; Ali Banihashemi; Vahid Kholghi Oskooei; Mandana Azizi; Ahmad Tamaddoni; Sadegh Sedaghat; Mohsen Vakili; Hassan Mahmoudi Nesheli; Soraya Shabani
Journal:  Int J Mol Cell Med       Date:  2012
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.